Germany
# |
Name |
Operating Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 5.93 B
|
Dec. 31, 2023 | USD 116.36 | -0.45% |
|
Germany |
|
2 |
USD 5.65 B
|
Dec. 31, 2023 | USD 20.20 | -1.60% |
|
Germany |
|
3 |
USD 4.18 B
|
Dec. 31, 2023 | USD 145.16 | 0.75% |
|
Germany |
|
4 |
USD 588.93 M
|
Dec. 31, 2023 | USD 49.86 | 0.81% |
|
Germany |
|
5 |
USD 51.82 M
|
Dec. 31, 2023 | USD 48.95 | 1.72% |
|
Germany |
|
6 |
USD 40.22 M
|
Dec. 31, 2023 | USD 8.09 | -2.02% |
|
Germany |
|
7 |
USD 21.44 M
|
Dec. 31, 2023 | USD 29.11 | 3.16% |
|
Germany |
|
8 |
USD 20.12 M
|
Dec. 31, 2023 | USD 5.97 | -4.48% |
|
Germany |
|
9 |
USD 19.33 M
|
Dec. 31, 2023 | USD 18.55 | -3.93% |
|
Germany |
|
10 |
USD 10.10 M
|
Dec. 31, 2023 | USD 4.18 | 0.60% |
|
Germany |
|
11 |
USD 3.49 M
|
Dec. 31, 2023 | USD 21.54 | 1.09% |
|
Germany |
|
12 |
USD -2.98 M
|
Dec. 31, 2023 | USD 42.87 | 0.60% |
|
Germany |
|
13 |
USD -3.23 M
|
Dec. 31, 2023 | USD 4.96 | -2.24% |
|
Germany |
|
14 |
USD -4.46 M
|
Sept. 30, 2023 | USD 3.68 | 1.46% |
|
Germany |
|
15 |
USD -10.87 M
|
Dec. 31, 2023 | USD 60.50 | -1.24% |
|
Germany |
|
16 |
USD -11.33 M
|
Dec. 31, 2023 | USD 1.49 | -0.76% |
|
Germany |
|
17 |
USD -16.69 M
|
Dec. 31, 2023 | USD 1.09 | 3.54% |
|
Germany |
|
18 |
USD -21.94 M
|
Dec. 31, 2023 | USD 5.29 | 13.28% |
|
Germany |
|
19 |
USD -23.78 M
|
Dec. 31, 2023 | USD 2.11 | 3.12% |
|
Germany |
|
20 |
USD -36.65 M
|
Nov. 30, 2023 | USD 2.61 | 0.60% |
|
Germany |
|
21 |
USD -41.74 M
|
Dec. 31, 2023 | USD 2.34 | NA |
|
Germany |
|
22 |
USD -84.12 M
|
Dec. 31, 2023 | USD 1.33 | -6.34% |
|
Germany |
|
23 |
USD -121.71 M
|
Dec. 31, 2023 | USD 1.07 | -4.46% |
|
Germany |
|
24 |
USD -295.68 M
|
Dec. 31, 2023 | USD 3.95 | -0.95% |
|
Germany |
The Biotechnology company in Germany with the highest Operating Cash Flow is BioNTech SE (Frankfurt Stock Exchange: 22UA.F) at USD 5.93 B.
The Biotechnology company in Germany with the lowest Operating Cash Flow is CureVac N.V. (Frankfurt Stock Exchange: 5CV.F) at USD -295.68 M.
The top 10 Biotechnology companies in Germany by Operating Cash Flow are BioNTech SE, Bayer Aktiengesellschaft, MERCK Kommanditgesellschaft auf Aktien, GEA Group Aktiengesellschaft, Eckert & Ziegler Strahlen- und Medizintechnik AG, Evotec SE, Stratec SE, Immatics N.V., technotrans SE and VITA 34 AG.
The bottom 10 Biotechnology companies in Germany by Operating Cash Flow are CureVac N.V., Affimed N.V., Atai Life Sciences N.V., InflaRx N.V., Heidelberg Pharma AG, Vivoryon Therapeutics N.V., Mainz Biomed B.V., Medigene AG, NanoRepro AG and Formycon AG.